Meeting Report from Chinese Anti-Cancer Association – Chinese Association of Nurses in Oncology
نویسنده
چکیده
366 The Second National Academic Conference in Oncology Nursing – International Forum in Oncology Nursing was held on March 9‐12, 2017 in Fu Zhou, Fujian Province, China. The conference is conducted every 2 years by the Chinese Association of Nurses in Oncology (CANO) of the Chinese Anti‐Cancer Association (CACA). CACA, founded in 1984, is the only national association in oncology in mainland China. CANO, which is under the CACA, was established on March 19, 2015. CACA has constantly led the national nursing community in transforming cancer care for cancer control by providing cancer patients with high‐quality, science‐based nursing care. Ten keynote speakers originating from mainland China, Hong Kong, United States, and Australia represented CACA–CANO, Asian Oncology Nursing Society (AONS), Oncology Nursing Society (ONS), and the International Society of Nurses in Cancer Care (ISNCC), respectively, in the conference. The speakers delivered their excellent keynote speeches at the plenary sessions. They highlighted the recent advances in oncology and implications for oncology nursing, which are global hot topics. Prof. Yates of ISNCC shared the scientific and technological advances in oncology over the past decades.
منابع مشابه
Translational Research in Oncology Research & Development and Its Impact on Early Development in China: report of the 5th Annual Meeting of the US Chinese Anti-Cancer Association (USCACA) at 2013 AACR Annual Meeting
In April 2013, the US Chinese Anti-Cancer Association (USCACA) held its 5th annual meeting in conjunction with the American Association for Cancer Research (AACR) 2013 Annual Meeting in Washington DC. The USCACA executive committee reported activities and programs and highlighted the partnership and collaboration between USCACA and other major organizations. The key initiatives and programs of ...
متن کاملGenomics in personalized cancer medicine and its impact on early drug development in China: report from the 6th Annual Meeting of the US Chinese Anti-Cancer Association (USCACA) at the 50th ASCO Annual Meeting
The 6th Annual Meeting of the United States Chinese Anti-Cancer Association (USCACA) was held in conjunction with the 50th Annual Meeting of American Society of Clinical Oncology (ASCO) on May 30, 2014 in Chicago, Illinois, the United States of America. With a focus on personalized medicine, the conference featured novel approaches to investigate genomic aberrations in cancer cells and innovati...
متن کاملBridging the US and China together to conquer cancer: report of the 4th annual meeting of the US Chinese Anti-Cancer Association (USCACA)
A global collaborative effort is pivotal to conquer cancer. Themed "Emerging role of China in global clinical development of novel anti-cancer drugs", the US Chinese Anti-Cancer Association (USCACA) held its 4th annual meeting in Chicago on June 2, 2012, in conjunction with the American Society of Clinical Oncology (ASCO) annual meeting to further bridge the US and China together to outsmart ca...
متن کاملThe USCACA hosted symposiums at the 7th CACA annual meeting and the 15th CSCO annual meeting in Beijing
In September 2012, the US Chinese Anti-Cancer Association (USCACA) hosted two symposiums in Beijing. The USCACA hosted the first joint session at the 7th annual meetings of the Chinese Anti-Cancer Association (CACA), themed on "Collaboration between the US and China in Cancer Research." Six experts from the United States and China presented their latest work on basic and translational cancer re...
متن کاملBreakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting
The US Chinese Anti-Cancer Association (USCACA) teamed up with Chinese Society of Clinical Oncology (CSCO) to host a joint session at the17th CSCO Annual Meeting on September 20th, 2014 in Xiamen, China. With a focus on breakthrough cancer medicines, the session featured innovative approaches to evaluate breakthrough agents and established a platform to interactively share successful experience...
متن کامل